Adaptive Biotechnologies Reaches Analyst Target Price
26/6 13:37
In recent trading, shares of Adaptive Biotechnologies Corp (Symbol: ADPT) have crossed above the average analyst 12-month target price of $11.62, changing hands for $11.98/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: dow...